COVID-19 prophylaxis with immunoglobulin Y (IgY) for the world population: The critical role that governments and non-governmental organizations can play.

Frumkin, Lyn R; Lucas, Michaela; Wallach, Michael; Scribner, Curtis L; St John, Tom; Mochly-Rosen, Daria

Frumkin, Lyn R; Lucas, Michaela; Wallach, Michael; Scribner, Curtis L; St John, Tom; Mochly-Rosen, Daria.

Frumkin LR; SPARK at Stanford, Stanford University, School of Medicine, Stanford, California, USA.
Lucas M; Medical School, The University of Western Australia, Perth, Western Australia, Australia.
Wallach M; University of Technology Sydney, Sydney, New South Wales, Australia.
Scribner CL; SPARK Sydney, Sydney, New South Wales, Australia.
St John T; Independent Regulatory Consultant, Oakland, California, USA.
Mochly-Rosen D; SPARK at Stanford, Stanford University, School of Medicine, Stanford, California, USA.

J Glob Health ; 12: 03080, 2022 Dec 03.

Article in English | MEDLINE | ID: covidwho-2155716

Subject(s)

COVID-19; Humans; COVID-19/prevention & control; Government; Immunoglobulins

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: J Glob Health Year: 2022 Document Type: Article Affiliation country: Jogh.12.03080

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google